195 related articles for article (PubMed ID: 17513868)
1. MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties.
Sun Q; Weber CR; Sohail A; Bernardo MM; Toth M; Zhao H; Turner JR; Fridman R
J Biol Chem; 2007 Jul; 282(30):21998-2010. PubMed ID: 17513868
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of the cellular glycosylphosphatidylinositol-linked membrane type-6 matrix metalloproteinase.
Radichev IA; Remacle AG; Shiryaev SA; Purves AN; Johnson SL; Pellecchia M; Strongin AY
J Biol Chem; 2010 May; 285(21):16076-86. PubMed ID: 20308072
[TBL] [Abstract][Full Text] [Related]
3. Identification and role of the homodimerization interface of the glycosylphosphatidylinositol-anchored membrane type 6 matrix metalloproteinase (MMP25).
Zhao H; Sohail A; Sun Q; Shi Q; Kim S; Mobashery S; Fridman R
J Biol Chem; 2008 Dec; 283(50):35023-32. PubMed ID: 18936094
[TBL] [Abstract][Full Text] [Related]
4. Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP.
Kojima S; Itoh Y; Matsumoto S; Masuho Y; Seiki M
FEBS Lett; 2000 Sep; 480(2-3):142-6. PubMed ID: 11034316
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization and N-terminomics analysis of leukolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemokine and vimentin cleavages enhance cell migration and macrophage phagocytic activities.
Starr AE; Bellac CL; Dufour A; Goebeler V; Overall CM
J Biol Chem; 2012 Apr; 287(16):13382-95. PubMed ID: 22367194
[TBL] [Abstract][Full Text] [Related]
6. MT6-MMP is present in lipid rafts and faces inward in living human PMNs but translocates to the cell surface during neutrophil apoptosis.
Fortin CF; Sohail A; Sun Q; McDonald PP; Fridman R; Fülöp T
Int Immunol; 2010 Aug; 22(8):637-49. PubMed ID: 20501611
[TBL] [Abstract][Full Text] [Related]
7. MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.
Sohail A; Sun Q; Zhao H; Bernardo MM; Cho JA; Fridman R
Cancer Metastasis Rev; 2008 Jun; 27(2):289-302. PubMed ID: 18286233
[TBL] [Abstract][Full Text] [Related]
8. Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils.
Matsuda A; Itoh Y; Koshikawa N; Akizawa T; Yana I; Seiki M
J Biol Chem; 2003 Sep; 278(38):36350-7. PubMed ID: 12860995
[TBL] [Abstract][Full Text] [Related]
9. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
[TBL] [Abstract][Full Text] [Related]
10. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
[TBL] [Abstract][Full Text] [Related]
12. Membrane-type 6 matrix metalloproteinase regulates the activation-induced downmodulation of CD16 in human primary NK cells.
Peruzzi G; Femnou L; Gil-Krzewska A; Borrego F; Weck J; Krzewski K; Coligan JE
J Immunol; 2013 Aug; 191(4):1883-94. PubMed ID: 23851692
[TBL] [Abstract][Full Text] [Related]
13. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).
English WR; Velasco G; Stracke JO; Knäuper V; Murphy G
FEBS Lett; 2001 Feb; 491(1-2):137-42. PubMed ID: 11226436
[TBL] [Abstract][Full Text] [Related]
14. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
15. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
[TBL] [Abstract][Full Text] [Related]
17. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
[TBL] [Abstract][Full Text] [Related]
18. Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils.
Kang T; Yi J; Guo A; Wang X; Overall CM; Jiang W; Elde R; Borregaard N; Pei D
J Biol Chem; 2001 Jun; 276(24):21960-8. PubMed ID: 11282999
[TBL] [Abstract][Full Text] [Related]
19. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation.
Hernandez-Barrantes S; Toth M; Bernardo MM; Yurkova M; Gervasi DC; Raz Y; Sang QA; Fridman R
J Biol Chem; 2000 Apr; 275(16):12080-9. PubMed ID: 10766841
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
